Drug reference
alogliptin-metformin
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Peptide analogues)
Mechanism of action
Alogliptin: Selective dipeptidyl peptidase-4 (DPP-4) inhibitor; slows inactivation of incretin hormones (eg, GLP-1, GIP), thereby reducing fasting and postprandial glucose concentrations in a glucose-dependent manner Metformin: Biguanide; decreases hepatic glucose production, decreases GI glucose absorption
Common side effects
- Upper respiratory tract infection
- Nasopharyngitis
- Headache
- Back pain
- Hypoglycemia
- Hypertension
- Diarrhea
Related conditions
Frequently asked questions
What drug class is alogliptin-metformin?
alogliptin-metformin belongs to: Endocrine.
How does alogliptin-metformin work?
Alogliptin: Selective dipeptidyl peptidase-4 (DPP-4) inhibitor; slows inactivation of incretin hormones (eg, GLP-1, GIP), thereby reducing fasting and postprandial glucose concentrations in a glucose-dependent manner Metformin: Biguanide; decreases hepatic glucose production, decreases GI glucose absorption
What are the common side effects of alogliptin-metformin?
Upper respiratory tract infection, Nasopharyngitis, Headache, Back pain, Hypoglycemia, Hypertension, Diarrhea
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.